Recent Updates

Modified on: 
Apr 25, 2018

Intravenous Immune Globulin

General Information

Intravenous immune globulin (IVIG) products are sterile solutions or lyophilized concentrates of human Immunoglobulin G (IgG) immunoglobulin that have been processed to remove multimers and aggregates of IgG thus allowing for intravenous infusion. The distribution of IgG subclasses is similar to that found in normal plasma. Depending on the method of preparation, some products may contain trace amounts of Immunoglobulin A (IgA) and Immunoglobulin M (IgM).  

Transfusion
Modified on: 
Apr 5, 2018

While the practice of transfusion of blood products to neonatal and pediatric recipients has much in common with the transfusion of blood products to adults, there are several important differences and special circumstances. This chapter highlights the most common considerations that are unique to this group of patients.

Transfusion
Modified on: 
Mar 1, 2018

Modified or specialty blood components may be useful in specific clinical settings to reduce the risk of transfusion-related harm. Specialty blood products available to physicians include CMV-seronegative, irradiated, and washed red blood cells or platelets. This chapter describes the preparation of these blood components and the clinical setting in which they are of greatest benefit.

Transfusion
Modified on: 
Feb 28, 2018

This chapter describes the manufacturing process for the most commonly prepared blood products: Red Blood Cells, Pooled Platelets, Frozen Plasma (FP), Apheresis Fresh Frozen Plasma (AFFP), Cryosupernatant Plasma (CSP) and Cryoprecipitate. A brief description of the indications, contraindications, storage and transportation requirements, dose, administration and available alternatives is included in the sections below. Further information may be found in other chapters of this Guide as indicated within the different sections.

Transfusion
Modified on: 
Feb 15, 2018

Author: Mindy Goldman, MD, FRCPC
Online publication date: March 2012, updated January 2018

Transfusion
Modified on: 
Feb 15, 2018

Led by project director Dr. Clinton Campbell and developed with funding from Canadian Blood Services' BloodTechNet program, a series of short, entertaining and informative animated videos present Choosing Wisely Canada transfusion recommendations.

Transfusion
Modified on: 
Feb 15, 2018

The BloodTechNet program was launched in 2011 to facilitate the development of innovative educational resources that support the Transfusion, Cellular Therapy and Transplantation communities in Canada. The program is led by Canadian Blood Services’ Centre for Innovation with financial support from Grifols. For information about the next BloodTechNet program competition, visit blood.ca research funding programs.

Transfusion
Organs and Tissues
Stem Cells
Modified on: 
Feb 7, 2018

By generously providing blood that can be manufactured into red blood cells, platelets and plasma products, whole blood donors are essential to the blood system and the patients it serves. Canadian Blood Services is committed to maintaining a safe and secure blood supply while also protecting the health of our blood donors. The focus of this article is the effect of red blood cell loss on the iron levels of the donor and the steps taken by Canadian Blood Services to protect the health of its donors.

Transfusion
Modified on: 
Feb 6, 2018
Canadian Blood Services delivers KnowledgeInfusion activities to disseminate research findings that are aligned with the goals of our organization in order to accelerate their uptake by the transfusion community. KnowledgeInfusion activities include Lunch&Learn webinars that are recorded and shared below. 
 

Extending platelet shelf life from 5 to 7 days

Transfusion

Pages